WNT1 and ovarian cancer: In addition, silencing miR-361-3p was significantly promoted the Wnt1 protein expression and β-catenin nuclear expression (Fig. 7), indicating that miR-361-3p inhibited Wnt/β-catenin signaling pathway in ovarian cancer.